Promising Findings on Kidney Function Preservation in IgA Nephropathy Patients at National Kidney Foundation Spring Clinical Meetings [Yahoo! Finance]
Travere Therapeutics, Inc. (TVTX)
Company Research
Source: Yahoo! Finance
maximally titrated irbesartan (MT-IRB) in patients with IgA nephropathy (IgAN) is set to be presented as a late-breaking presentation at the annual 2024 National Kidney Foundation Spring Clinical Meetings this week in Long Beach, CA. "Matching-Adjusted Indirect Comparisons of eGFR Slopes in the PROTECT Study With UK RaDaR IgA Nephropathy Population and the Control Arm of NefIgArd" delves into the comparison of 2-year estimated glomerular filtration rate (eGFR) total slopes between the sparsentan and MT-IRB arms of the PROTECT clinical trial and standard of care (SoC) in real-world and clinical trial settings. The work was conducted by a collaborative team of researchers from Travere Therapeutics, Analysis Group, JAMCO Pharma Consulting, Ohio State University , and the University of Leicester. The PROTECT trial was specifically designed to assess the long-term nephroprotective effects of sparsentan compared to MT-IRB in IgAN patients. By comparing outcomes with real-world data from
Show less
Read more
Impact Snapshot
Event Time:
TVTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TVTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TVTX alerts
High impacting Travere Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TVTX
News
- Travere (TVTX) Stock Jumps 5.2%: Will It Continue to Soar? [Yahoo! Finance]Yahoo! Finance
- Shareholders in Travere Therapeutics (NASDAQ:TVTX) are in the red if they invested five years ago [Yahoo! Finance]Yahoo! Finance
- American Kidney Fund Convenes Rare Kidney Disease Action Network to Advocate for Policies and Regulations that Help Patients with Rare Causes of Kidney Disease [Yahoo! Finance]Yahoo! Finance
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Why Is Ligand (LGND) Up 4% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
TVTX
Earnings
- 5/6/24 - Miss
TVTX
Sec Filings
- 6/14/24 - Form S-8
- 5/13/24 - Form 8-K
- 5/10/24 - Form 4
- TVTX's page on the SEC website